Adjunctive Hyperbaric Oxygen Treatment for... (2026 study) Skip to main content
Case Report Wilderness Environ Med 2026

Adjunctive Hyperbaric Oxygen Treatment for Grade-Four Frostbite: A Case Study and Short Discussion From Tasmania, Australia

Stevens G, Wilderness Environ Med, 2026

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Doctors describe one patient with severe (grade 3-4) frostbite in both feet who was treated with hyperbaric oxygen therapy along with other standard treatments.

What They Found

This case report describes a patient who developed frostbite three days after an 11-day walk in cold, snowy, wet conditions in Tasmania, Australia, and was treated with hyperbaric oxygen along with vasodilator and rheological (blood flow-improving) drugs. The treatment seemed to reduce the area of poor blood flow (ischemia) in both feet. The authors state this possibly reduced how much of the toe joints needed to be amputated. No specific pressure, session count, or numeric outcome measures are reported in the abstract.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This is a single case report from one patient with no comparison group, so it cannot establish that hyperbaric oxygen caused the outcome or predict results in other patients.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Report
Category Neurological
Source Pubmed
PubMed ID 40853603
Year Published 2026
Journal Wilderness Environ Med
MeSH Terms Humans; Hyperbaric Oxygenation; Frostbite; Male; Tasmania; Vasodilator Agents; Adult

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology